KensaGroup creates, launches and develops leading edge intellectual property platforms into successful technology-based businesses. KensaGroup uses a proprietary approach to identify and evaluate promising discoveries from universities and corporate research initiatives, then creates the necessary scientific, institutional, and financial bridges that lead from initial discovery to successful commercialization.
01.07.20 - GNS Healthcare announces strategic investment from Merck Global Health Investment Fund...more
11.22.19 - Novomer Announces Appointment of Jeff Uhrig As Chief Executive Officer...more
07.09.19 - Cigna, Celgene join $23M funding round for AI-powered GNS Healthcare...more
07.02.19 - Discovery of New Clinical Predictors of Overall Survival in Metastatic Colorectal Cancer at ESMO 2019 in Collaboration with the Alliance for Clinical Trials in Oncology...more
05.09.19 - New Grainful flavors launching at Target...more
KensaGroup, LLC
2415 N. Triphammer Road
Ithaca, NY 14850
phone: 1.607.330.2307
Fax: 1.607.257.1139